Browse categories and answer follow-up questions to refine your symptom profile.
Approach to the Critical Patient
Immediate Threats
Life threats
Airway edema with stridor
Escalate to resuscitation bay
If impending obstruction, prepare awake fiberoptic intubation
Cerebral edema
Declining mental status
Seizure
Hemodynamic compromise
Obstructive shock physiology
Severe hypoxemia
Rapidly progressive symptoms
Onset hours to days
Inability to lie flat
First Actions
Stabilization priorities
Upright positioning
Head of bed 30-60 degrees
Avoid supine positioning if dyspnea
Oxygen strategy
Nasal cannula to target SpO2 92-96%
Noninvasive ventilation if work of breathing high and airway stable
Vascular access strategy
Avoid upper extremity IV if feasible
Femoral IV access for unstable patient
If central access needed, femoral venous catheter
Monitoring
Continuous pulse oximetry
Cardiac monitor
Frequent neurologic reassessment
Early Consultation Triggers
Team activation
If airway compromise, anesthesia and ENT
Difficult airway cart
Awake technique planning
If suspected malignancy, oncology and radiation oncology
Tissue diagnosis planning
Urgent therapy coordination
If suspected catheter associated thrombosis, interventional radiology and vascular medicine
Anticoagulation planning
Endovascular therapy candidacy
If severe symptoms, interventional radiology for stent
Symptom relief within hours
Bridge to definitive cancer therapy
Key Concepts
Working diagnosis framework
Obstruction mechanism
External compression
Intraluminal thrombosis
Combined compression and thrombosis
Time critical phenotype
Rapid progression suggests thrombosis or aggressive tumor
Indolent progression suggests slowly growing mass
Goals of ED care
Protect airway and brain
Confirm anatomy and cause
Coordinate definitive therapy
History
Presenting Pattern
Symptom pattern
Facial swelling
Worse in morning
Worse with bending forward
Neck and upper extremity swelling
Tight rings
Shirt collar tightness
Dyspnea
Orthopnea
Positional worsening supine
Cough
Persistent
Hemoptysis
Head symptoms
Headache
Visual changes
Dizziness
Neurologic symptoms
Confusion
Syncope
Seizure
High Risk Features
Red flags
Stridor
Voice change
Drooling
Altered mental status
Lethargy
Agitation
Rapid progression
Hours to days
New severe dyspnea
Venous congestion signs
Severe facial plethora
Marked conjunctival edema
Etiology Clues
Malignancy clues
Weight loss
Night sweats
Fatigue
Smoking history
Chronic cough history
Prior lung cancer
Lymphoma symptoms
B symptoms
Lymphadenopathy history
Thrombosis clues
Indwelling venous device
PICC
Port
Dialysis catheter
Recent line manipulation
New catheter placement
Recent infusion complications
Hypercoagulable risks
Active cancer
Recent surgery
Estrogen exposure
Infection and inflammatory clues
Mediastinal infection history
TB exposure
Histoplasmosis exposure
Prior radiation
Mediastinal fibrosis risk
Physical Exam
General and Vitals
Severity markers
Respiratory distress
Accessory muscle use
Tripod positioning
Mental status changes
Confusion
Somnolence
Hemodynamic instability
Hypotension
Tachycardia
Positional intolerance
Unable to lie flat
Marked orthopnea
Head and Neck
Venous congestion findings
Facial edema
Periorbital edema
Facial plethora
Neck swelling
Supraclavicular fullness
Neck vein distention
Oropharyngeal edema
Tongue swelling
Uvular edema
Airway sounds
Stridor
Hoarseness
Chest and Extremities
Collateral circulation
Chest wall venous distention
Prominent superficial veins
Venous flow direction changes
Upper extremity edema
Bilateral swelling
Cyanosis
Cardiopulmonary exam
Wheeze
Tumor related airway compression
Reduced breath sounds
Pleural effusion
Atelectasis
PITFALLS
Common misses
Misattribution to angioedema
Lack of urticaria
Prominent venous distention
Missed catheter associated thrombosis
Recent line placement
Unilateral arm swelling progressing to bilateral
Delayed airway planning
Sedation induced collapse risk
Supine decompensation risk
Differential Diagnosis
Life Threatening Mimics
Critical alternatives
Anaphylaxis
ICD-10 T78.2
Urticaria and hypotension pattern
Angioedema
ICD-10 T78.3
Lip and tongue swelling without venous distention
Massive pulmonary embolism
ICD-10 I26.99
Obstructive shock physiology
Tension pneumothorax
ICD-10 J93.0
Unilateral absent breath sounds
Cardiac tamponade
ICD-10 I31.4
Pulsus paradoxus
Superior mediastinal hemorrhage
ICD-10 J94.2
Trauma or procedure history
Causes of Superior Vena Cava Obstruction
Malignant causes
Lung cancer
Small cell lung carcinoma
Non small cell lung carcinoma
Non Hodgkin lymphoma
Mediastinal mass
Metastatic tumors
Breast cancer
Germ cell tumor
Thymic malignancy
Thymoma
Thrombotic causes
Catheter associated thrombosis
SNOMED CT central venous catheter related thrombosis
Upper extremity deep vein thrombosis with extension
ICD-10 I82.62
Hypercoagulability
Malignancy associated thrombosis
Benign extrinsic causes
Fibrosing mediastinitis
Post histoplasmosis
Post TB
Aortic aneurysm mass effect
ICD-10 I71.2
Retrosternal goiter
ICD-10 E04.9
Laboratory Tests
Baseline and Safety Labs
Initial labs
Complete blood count
Anemia and thrombocytopenia affecting procedure planning
Leukocytosis suggesting infection
Electrolytes and renal function
Contrast planning for CT venography
Tumor lysis baseline risk context
Liver tests
Metastatic disease clue
Medication safety
Coagulation profile
Anticoagulation safety
Procedure readiness
Malignancy and Complication Screening
Cancer related labs
LDH
Lymphoma support
High tumor burden clue
Uric acid mmol/l
Tumor lysis risk
If high, early prophylaxis planning
Phosphate mmol/l
Tumor lysis risk
Calcium mmol/l
Malignancy related derangements
Thrombosis Workup Adjuncts
Thrombosis related labs
D dimer
Limited utility in known high risk cancer
Not definitive for exclusion
Troponin
Alternative diagnosis support in dyspnea
BNP
Alternative diagnosis support in dyspnea
Diagnostic Tests
Scoring Systems
Severity stratification
Symptom severity classification
Mild
Facial edema without dyspnea at rest
Able to tolerate supine
Moderate
Dyspnea with minimal exertion
Headache and visual symptoms
Severe
Stridor
Confusion or syncope
Hemodynamic instability
Kishi score concept
Points based on neurologic symptoms
Points based on laryngeal edema
Points based on facial and upper extremity edema
Higher score correlates with need for urgent stent
MRI
MR venography role
Contrast allergy alternative
Non contrast MR sequences possible
Gadolinium risk assessment in renal failure
Soft tissue characterization
Tumor extent
Vascular invasion
Limitations
Longer acquisition time
Unstable patient not suitable
Pacemaker and implant constraints
CT
CT chest with contrast
Primary diagnostic test
Defines obstruction level
Identifies mass and lymphadenopathy
CT venography protocol
Upper extremity injection can be suboptimal
If possible, lower extremity injection strategy in severe obstruction
Findings supporting SVCS
Narrowed or occluded SVC
Extensive venous collaterals
Mediastinal mass effect
Complication assessment
Airway compression
Pericardial effusion
Pleural effusion
Ultrasound
Bedside and vascular ultrasound
Upper extremity venous duplex
Axillary and subclavian thrombosis
Catheter associated thrombus
POCUS cardiopulmonary adjuncts
Pericardial effusion
Pleural effusion
Right heart strain alternative diagnosis context
Limitations
Poor visualization of central SVC
Negative duplex does not exclude central obstruction
Disposition
Level of Care
Admission criteria
Severe symptoms
Stridor or airway edema
Hypoxemia requiring high flow oxygen or NIV
Neurologic symptoms
Hemodynamic instability
Need for urgent intervention
Endovascular stent planning
Urgent radiation or chemotherapy planning
Anticoagulation with high bleeding risk
New diagnosis of mediastinal mass
Tissue diagnosis pathway
Multidisciplinary coordination
ICU criteria
Airway risk
Stridor
Rapid progression
Cerebral edema concern
Confusion
Seizure
Hemodynamic compromise
Shock
Severe hypoxemia
Transfer Criteria
Higher level resources needed
Interventional radiology stenting not available
Severe symptoms needing rapid relief
Oncology and radiation services not available
Suspected chemo or radiation responsive tumor
Thoracic surgery backup needed
Complex mediastinal mass with airway compression
Treatment
Supportive Measures
Symptom mitigation
Upright positioning
Avoid supine
Sleep with head elevated
Oxygen therapy
Titrate to SpO2 92-96%
Fluid strategy
Avoid aggressive fluids unless hypotension
Diuresis only if volume overload
Access strategy
Femoral venous access
Avoid upper extremity infusion when possible
Airway and Cerebral Edema Management
High risk airway approach
If stridor, early expert airway
Awake fiberoptic intubation preferred
Avoid paralytic induced loss of airway tone if possible
If emergent airway, prepare surgical airway backup
ENT at bedside if available
Cricothyrotomy equipment ready
Cerebral edema adjuncts
Dexamethasone IV 10 mg once then 4 mg IV every 6 hours
Preferred when lymphoma suspected
Potential to obscure lymphoma histology
Hypertonic saline 3% 2 ml/kg IV bolus for severe neurologic symptoms
Serum sodium target 145-155 mmol/l
Avoid in chronic hyponatremia without close monitoring
Anticoagulation and Thrombosis Therapy
Catheter associated thrombosis
Initiate anticoagulation if no contraindication
Unfractionated heparin infusion
Bolus 80 units/kg IV
Infusion 18 units/kg/hour
Titrate to institutional aPTT target
Enoxaparin 1 mg/kg SC every 12 hours
Avoid if CrCl severely reduced
Catheter management
If line no longer needed, remove after anticoagulation initiated
If line needed, maintain with anticoagulation unless infected
Thrombolysis considerations
If acute onset under 14 days and severe symptoms, catheter directed thrombolysis via interventional radiology
Intracranial hemorrhage and recent surgery as major contraindications
Endovascular Therapy
SVC stenting
Indications
Severe symptoms
Rapid progression
Need for immediate relief prior to tissue diagnosis
Expected response
Symptom improvement within 24-72 hours
Often within hours
Periprocedural considerations
Contrast nephropathy risk mitigation
Anticoagulation or antiplatelet regimen per interventional radiology protocol
Evidence level framing
Endovascular stent as first line for severe malignant SVCS supported by expert consensus Class I recommendation
Tumor Directed Therapy
Radiation therapy
Indications
Radiosensitive tumor with confirmed or strongly suspected diagnosis
Non stent candidates
Limitations
Slower symptom relief than stent
Risk of obscuring future biopsy yield in some settings
Chemotherapy
Indications
Small cell lung carcinoma
Lymphoma
Coordination
Oncology led regimen selection
Tumor lysis prevention planning when high burden suspected
Adjunct Medications
Steroids role
Dexamethasone IV regimen for suspected lymphoma as above
Use after biopsy plan clarified when feasible
Earlier use when airway or cerebral compromise present
Diuretics role
Limited evidence for venous obstruction relief
Use only for concomitant heart failure or volume overload
Furosemide 20-40 mg IV once
Analgesia and anxiolysis
Avoid heavy sedation in airway risk
Small incremental doses if needed
Continuous monitoring
Special Populations
Pregnancy
Pregnancy considerations
Imaging strategy
CT chest with shielding when urgent and benefits outweigh risks
MRI as alternative when stable and available
Thrombosis risk higher
Lower threshold for anticoagulation when thrombus confirmed
Anticoagulation choice
LMWH preferred in pregnancy
Avoid warfarin
Multidisciplinary care
Obstetrics involvement early
Maternal oxygenation priority
Geriatric
Older adult considerations
Comorbidity burden
Heart failure overlap
Renal impairment affecting contrast and LMWH
Medication sensitivity
Lower sedation tolerance
Higher bleeding risk with anticoagulation
Malignancy likelihood high
Rapid diagnostic pathway
Goals of care discussions early when appropriate
Pediatrics
Pediatric considerations
Etiology differences
Lymphoma more common than lung cancer
Congenital venous anomalies in differential
Airway risk
Smaller airway diameter
Lower threshold for specialist airway involvement
Weight based therapy
Dexamethasone 0.15 mg/kg IV every 6 hours
Maximum 4 mg per dose
Radiation avoidance when possible
Prefer chemo for lymphoma when feasible
Coordinate pediatric oncology urgently
Background
Epidemiology
Epidemiology overview
Malignancy most common cause in adults
Lung cancer leading cause
Lymphoma important cause
Increasing device related thrombosis
Higher PICC and port use
Dialysis catheter contribution
Benign causes minority but clinically important
Fibrosing mediastinitis
Post radiation stenosis
Pathophysiology
Mechanism
SVC obstruction elevates venous pressure upstream
Head and neck venous congestion
Upper extremity edema
Collateral formation
Azygos system recruitment
Chest wall superficial veins
Severe obstruction consequences
Reduced cerebral venous drainage
Airway edema from venous congestion
Thrombosis pathway
Catheter endothelial injury
Hypercoagulability in cancer
Therapeutic Considerations
Treatment rationale
Stent provides fastest symptom relief
Restores venous patency mechanically
Bridge to definitive cancer therapy
Tumor directed therapy treats underlying cause
Chemo for chemosensitive tumors
Radiation for radiosensitive tumors
Anticoagulation prevents propagation in thrombotic SVCS
Essential for catheter associated thrombosis
Often combined with endovascular therapy
Steroid use context dependent
Most useful for lymphoma and edema
Risk of masking lymphoma histology
Patient Discharge Instructions
copy discharge instructions
Home care and follow up
Sleep with head elevated
Avoid lying flat if worsens breathing
Upright positioning for symptom relief
Avoid upper extremity venipuncture and tight clothing
No blood pressure cuffs on affected arm if arm swelling
Loose collars and shirts
Follow up plan
Oncology appointment within 24-72 hours if suspected cancer
Vascular or interventional radiology follow up if stent placed
Anticoagulation clinic follow up if on blood thinner
Return immediately
Trouble breathing at rest
New noisy breathing
Stridor
New confusion
Fainting
Seizure
Rapidly worsening face or neck swelling
Inability to swallow saliva
Voice change
Chest pain
Hemoptysis
Anticoagulation complications
Black stools
Vomiting blood
Severe headache
References
Clinical Guidelines and Evidence
Reference set
Expert consensus supports endovascular stenting for severe symptomatic SVCS as rapid relief strategy Class I recommendation
Preferred when immediate symptom control needed
Bridge to oncologic therapy
Anticoagulation recommended for catheter associated upper extremity thrombosis with extension into central veins Class I recommendation
LMWH or UFH based on renal function and bleeding risk
Catheter directed thrombolysis for selected acute severe cases Class IIa recommendation
Steroids recommended when lymphoma suspected with airway or cerebral compromise based on expert consensus Class IIa recommendation
Use may reduce diagnostic yield for lymphoma biopsy
Prioritize tissue diagnosis when feasible
CT chest with contrast as primary anatomic test for suspected SVCS supported by broad guideline consensus ACEP Level B style evidence framing
Defines level of obstruction and etiology
Guides endovascular planning
Source artifact instructions
SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.